Knowledge of the ecology of the human microflora and of the role some of these organisms play in enhancing or interfering with infection offers new prospects for prevention and treatment of disease, but as yet little is known regarding these phenomena (5, 6) . Neisseria gonorrhoeae, for example, is an important pathogen isolated from body sites (cervix, throat, and rectum) that normally contains a variety of other microorganisms, but little information is currently available about interactions of N. gonorrhoeae with these microorganisms (2, 4) .
We have reported (3) the identification of a factor produced by all Candida albicans isolates tested which inhibited 60% of the N. gonorrhoeae isolates tested. As this pathogen and this yeast may occur together in vivo and are isolated occasionally from the same clinical specimens, .it was important to investigate these apparent failures of inhibition. Do all the gonococci isolated with the yeast belong to the resistant group, or are there some C. albicans strains that do not produce this factor?
Thirty-four specimens received in our laboratory that were positive for both N. gonorrhoeae and yeast were examined. Both the gonococci and the yeast were isolated, purified, and identified by established procedures (1; W. D. Lawton, submitted for publication). In four specimens the yeast was not C. albicans. In three other specimens, oxidase-positive gramnegative diplococci were seen but could not be isolated on subculture for confirmation. For the remaining 27 specimens, each C. albicans isolate was tested by our cross-streak method (3) against four gonococcal isolates previously found to be susceptible to inhibition by C. albicans. All 27 C. albicans isolates were shown to possess inhibitory activity, as evidenced by failure of the gonococci to grow over or near the yeast streak (3) .
On the other hand, when each of the 27 N. gonorrhoeae isolates was tested against the C. albicans with which it had arrived and against five C. albicans isolates previously shown to be good factor producers (giving > 1.0-cm inhibition), three different groups were observed. Group 1. Nine N. gonorrhoeae isolates (33%) were resistant to all C. albicans isolates. This prevalence of resistant strains is similar to the 40% originally reported. Group 2. Twelve N. gonorrhoeae isolates (44%) were resistant to the C. albicans with which they arrived but not to the other five isolates. Since the 12 C. albicans isolates arriving with this group were shown to produce the inhibitory factor, these results indicate that there are variations in gonocidal efficiency depending on the particular combination of N. gonorrhoeae and C. albicans. It is possible that not all Candida isolates produce the identically same factor, but a more likely explanation is that various isolates produce different amounts of the same factor. Studies to characterize the factor are in progress. Group 3. Six N. gonorrhoeae isolates (22%) were sensitive to all C. albicans isolates. This was probably an "escape" group in which the inhibitory level of yeast factor was not attained, possibly because of early isolation or because only a small number of C. albicans organisms were present in the original specimens. There was no correlation, however, to the transit time or to the lag period before growth, and it was not possible to correlate these findings to the numbers of C. albicans cells in each specimen, as the Good factor producers, i.e., giving greater than 1.0-cm inhibition from yeast growth on cross-streaking.
results had been recorded qualitatively rather than quantitatively.
These groups are summarized in Table 1 , and each is represented in Fig. 1 .
These findings do not answer the question of whether a woman carrying C. albicans in her genital tract may be more resistant to infection by some types of N. gonorrhoeae. They do suggest, however, that we can be certain of isolating gonococci only from those patients where the gonococci present are resistant to the accompanying C. albicans. Moreover, this separation of N. gonorrhoeae into at least three biotypes might be a useful epidemiologic tool and is currently being evaluated in our laboratory.
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